The Day In Review: Biotech Flat On The Week

August 5, 2005 Biotech gave up same more gains today, ending the week about 5 points lower than where it began. Today, the Centient Biotech 200 was off by 40 points at 3730.11, a 1.07% loss. Protein Design Labs traded higher after releasing its Q2 earnings report, Advanced Life Sciences Holdings priced its IPO at $5 per share, far below its proposed price, ReNeuron Group held its second IPO, Pozen abandoned its migraine drug in favor of a newer version, Neose Technologies laid off 25% of its workforce, DOV Pharmaceuticals began a Phase III trial of a new type of pain medication, and Impax Labs will be delisted from Nasdaq, because it has not filed its 2004 financial reports. More details...